Rolf Angerbauer

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

Hilmar Bischoff, Rolf Angerbauer, Joachim Bender et al. · Atherosclerosis · 1997 · 109 citations

Oxysterol, Biochemistry, Medicine +5

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.

Michael Boberg, Rolf Angerbauer, Peter Fey et al. · PubMed · 1997 · 77 citations

Metabolomic Profiling, Primary Metabolic Pathways, Cerivastatin Metabolism +19

A convenient preparation of 2,3-unsaturated N-galactosyl derivatives

Richard R. Schmidt, Rolf Angerbauer · Carbohydrate Research · 1979 · 49 citations

Chemistry, 2,3-Unsaturated N-galactosyl Derivatives, Chemical Derivative +2

Simple <i>de‐novo</i> Synthesis of Reactive Pseudoglycals (Hex‐2‐enopyranosides)—Stereospecific α‐Glycoside Coupling

Richard R. Schmidt, Rolf Angerbauer · Angewandte Chemie International Edition in English · 1977 · 49 citations

Biosynthesis, Derivatives, Engineering +13

Biotransformation of cerivastatin in mice, rats, and dogs in vivo.

Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai et al. · PubMed · 1998 · 45 citations

Pharmacological Study, Biochemistry, Medicine +12